DE ROCCO, GIUSEPPINA
DE ROCCO, GIUSEPPINA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Targeting neuronal circuits as a new frontier in Rett syndrome treatment
2025 A. De Donato, G. De Rocco, M. Indrigo, V. Varotto, A. Cantamessa, F. Bedogni, N. Landsberger
Unveiling the effect of early glutamatergic stimulation for Rett syndrome treatment
2025 A. De Donato, G. De Rocco, M. Indrigo, V. Varotto, A. Cantamessa, F. Bedogni, N. Landsberger
Targeting early network dysfunction in Rett syndrome through AMPA-receptor modulation
2025 G. De Rocco, A. De Donato, V. Varotto, M. Indrigo, A. Frasca, N. Landsberger
PHARMACOLOGICAL MODULATION OF NEURONAL ACTIVITY FOR THE TREATMENT OF RETT SYNDROME
2024 G. DE ROCCO
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models
2024 A. Esposito, T. Seri, M. Breccia, M. Indrigo, G. De Rocco, F. Nuzzolillo, V. Denti, F. Pappacena, G. Tartaglione, S. Serrao, G. Paglia, L. Murru, S. De Pretis, J. Cioni, N. Landsberger, F.C. Guarnieri, M. Palmieri
Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice
2024 D. Pozzer, M. Indrigo, M. Breccia, E. Florio, C.A. Franchino, G. De Rocco, F. Maltecca, A. Fadda, M. Rossato, A. Aramini, M. Allegretti, A. Frasca, L. De Filippis, N. Landsberger
Pharmacological modulation of neuronal activity to treat Rett syndrome
2023 G. De Rocco, L. Scaramuzza, M. Indrigo, A. Cantamessa, N. Landsberger
Pharmacological modulation of neuronal activity for the treatment of Rett syndrome
2023 G. De Rocco, L. Scaramuzza, M. Indrigo, A. Cantamessa, I. Sormonta, N. Landsberger
A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain
2023 S. Carli, L. Chaabane, G. De Rocco, E. Albizzati, I. Sormonta, S. Calligaro, P. Bonizzi, A. Frasca, N. Landsberger
Pharmacological modulation of neuronal activity for the treatment of Rett syndrome
2022 G. De Rocco, L. Scaramuzza, M. Indrigo, N. Landsberger
Pharmacological modulation of neuronal activity for the treatment of Rett syndrome
2022 G. De Rocco, L. Scaramuzza, M. Indrigo, A. Cantamessa, I. Sormonta, N. Landsberger
Neural precursor/stem cell-based therapy for Rett syndrome
2022 A. Frasca, F. Miramondi, E. Butti, M. Indrigo, G. DE ROCCO, F. Bedogni, G. Martino, N. Landsberger
The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes
2021 G. De Rocco, L. Scaramuzza, G. Desiato, F. Chiacchiaretta, A. Mustaccia, M. De Simone, F. Bedogni, N. Landsberger
Pharmacological modulation of neuronal activity for the treatment of Rett syndrome
2021 G. De Rocco, L. Scaramuzza, I. Sormonta, M. Indrigo, N. Landsberger
The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes
2021 L. Scaramuzza, G. De Rocco, G. Desiato, C. Cobolli Gigli, M. Chiacchiaretta, F. Mirabella, D. Pozzi, M. De Simone, P. Conforti, M. Pagani, F. Benfenati, F. Cesca, F. Bedogni, N. Landsberger